respiratori
tract
infect
present
common
cold
rhinosinus
tonsillopharyng
otiti
media
tracheobronch
without
airway
obstruct
highli
preval
among
young
children
infect
impact
children
health
wellb
also
gener
high
medic
cost
indirect
cost
famili
societi
inde
averag
young
children
experi
upper
respiratori
tract
infect
per
year
grow
older
incid
infect
decreas
probabl
result
matur
immun
defens
improv
anatom
condit
common
pathogen
involv
etiolog
recurr
respiratori
infect
human
rhinovirus
hrv
adenoviru
parainfluenza
viru
respiratori
syncyti
viru
enteroviru
human
metapneumoviru
coronaviru
addit
influenza
virus
rhinoviru
major
pathogenet
role
play
rhinovirus
frequent
caus
agent
upper
lower
respiratori
tract
infect
infant
young
children
abl
induc
broad
varieti
clinic
outcom
rang
asymptomat
infect
sever
respiratori
diseas
requir
hospit
protect
highli
special
innat
adapt
immun
system
surfac
respiratori
tract
act
select
barrier
maintain
integr
tissu
compart
imped
entri
inhal
major
microbi
pathogen
irrit
allergen
besid
provid
physic
function
barrier
extern
agent
airway
epitheli
cell
also
activ
involv
initi
host
inflammatori
immun
respons
releas
earli
inflammatori
mediat
activ
surfac
pattern
recognit
receptor
detect
environment
stimuli
airway
epitheli
cell
secret
endogen
danger
signal
therebi
activ
dendrit
cell
bridg
innat
adapt
immun
extens
research
role
inflammatori
mediat
pathogenesi
respiratori
insuffici
syndrom
ri
produc
evid
increas
concentr
sever
mediat
kinin
leukotrien
histamin
interleukin
tumor
necrosi
factor
tnf
regul
activ
normal
cell
express
secret
rant
nasal
secret
patient
cold
host
respons
mechan
trigger
viral
infect
efficaci
protect
host
howev
extrem
complex
far
resolv
furthermor
exagger
inflammatori
reaction
may
increas
damag
airway
level
rather
protect
infect
sever
studi
shown
atopi
attend
larg
daycar
associ
common
respiratori
infect
preschool
year
minor
patient
partial
iga
andor
igg
subclass
defici
demonstr
howev
defect
immatur
inflammatori
andor
immun
respons
airway
epitheli
level
may
also
involv
background
studi
design
evalu
vitro
whether
pidotimod
synthet
dipeptid
activ
innat
adapt
immun
could
modul
airway
epitheli
cell
function
involv
respons
respiratori
infect
evalu
intercellular
adhes
molecul
icam
toll
like
receptor
tlr
express
interleukin
il
releas
investig
possibl
involv
protein
complex
nuclear
factor
kappalightchainenhanc
activ
b
cell
nfkb
activ
extracellularsignalregul
kinas
erk
phosphoryl
human
bronchial
epitheli
cell
line
atcc
manassa
va
usa
deriv
human
bronchial
epithelium
transform
adenoviru
hybrid
viru
use
experi
cell
retain
electron
microscop
featur
epitheli
cell
show
posit
stain
antibodi
cytokeratin
grown
monolay
mixtur
laboratori
human
carcinogenesi
lhc
medium
invitrogen
srl
milan
itali
rpmi
medium
euroclon
milan
itali
pidotimod
puriti
gentli
provid
valea
spa
milan
itali
stock
standard
solut
prepar
pb
concentr
mgml
treat
pidotimod
ngml
zymosan
use
alon
associ
differ
time
h
percent
viabil
measur
trypan
blue
dye
exclus
test
euroclon
spa
mi
itali
cell
count
neubauer
chamber
viabl
cell
detect
base
abil
exclud
dye
nonviabl
cell
blue
due
defect
cell
membran
cell
grown
confluenc
well
cultur
plate
presenc
pidotimod
ngml
zymosan
use
alon
associ
pretreat
pidotimod
differ
time
stimul
zymosan
anoth
h
analysi
cell
incub
fitcconjug
mous
anti
invitrogen
srl
san
giuliano
milanes
itali
antimous
santa
cruz
biotechnolog
inc
segrat
milan
itali
antibodi
h
express
detect
use
goat
antimous
antibodi
alexa
invitrogen
cell
wash
resuspend
pb
immedi
analyz
fac
calibur
flow
cytomet
becton
dickson
milan
itali
use
cell
quest
softwar
mean
fluoresc
intens
compar
control
stain
use
irrelev
isotypematch
mous
monoclon
antibodi
cell
cultur
glass
labtek
slide
nalg
nunc
intern
differ
experiment
condit
cell
treat
pidotimod
ngml
use
alon
associ
h
cell
fix
icecold
methanol
min
block
label
mous
anti
ab
santa
cruz
biotechnolog
goat
antimous
antibodi
alexa
invitrogen
cell
incub
h
ngml
zymosan
pidotimod
absenc
presenc
zymosan
treatment
supernat
collect
level
quantifi
enzymelink
immunosorb
assay
elisa
kit
r
system
minneapoli
usa
accord
manufactur
instruct
analysi
cell
grown
confluenc
well
plate
treat
pidotimod
ngml
zymosan
use
alon
associ
h
analysi
cell
equal
plate
cultur
confluenc
expos
pidotimod
pidotimod
min
treatment
cell
scrape
lyse
lysi
buffer
mm
buffer
ph
contain
mm
nacl
mm
edta
egta
mm
sodium
orthovanad
vv
triton
mm
pmsf
leupeptin
aprotinin
min
ice
lysat
centrifug
g
min
cell
grow
confluenc
well
plate
treat
pidotimod
pidotimod
h
extract
prepar
use
method
describ
lesli
j
crofford
briefli
cell
resuspend
cytoplasm
buffer
mm
hepe
ph
mm
mm
edta
mm
egta
mm
dithiothreitol
dtt
proteas
inhibitor
ice
minut
triton
ad
final
concentr
intact
nuclei
pellet
centrifug
cytoplasm
extract
immedi
frozen
nuclei
resuspend
highsalt
buffer
mm
hepe
ph
mm
naci
mm
edta
mm
egta
mm
dtt
proteas
inhibitor
min
nuclear
extract
collect
centrifug
g
min
protein
concentr
lysat
measur
use
biorad
protein
assay
equal
amount
protein
resolv
sdspage
transfer
pvdf
membran
membran
blot
nfkb
santa
cruz
biotechnolog
total
phosphoryl
cell
signal
technolog
beverli
usa
gapdh
novu
biolog
inc
segrat
milan
itali
lamin
ac
santa
cruz
biotechnolog
inc
segrat
milan
itali
incub
hprconjug
antirabbit
antimous
antibodi
cell
signal
technolog
band
detect
use
enhanc
chemoluminesc
ecl
pierc
celbio
itali
relev
band
intens
quantifi
use
versadoc
imag
system
model
biorad
laboratori
hercul
ca
usa
statist
evalu
perform
use
statist
softwar
packag
graphpad
prism
graphpad
softwar
san
diego
ca
usa
result
express
mean
standard
error
mean
sem
test
test
use
probabl
valu
p
consid
statist
signific
assess
cell
trypan
blue
dye
exclus
test
show
h
incub
cell
viabil
similar
cultur
contain
pidotimod
e
zymosan
pidotimod
plu
zymosan
shown
similar
result
obtain
expos
cell
h
shown
investig
effect
pidotimod
express
cell
expos
pidotimod
ngml
pretreat
pidotimod
differ
time
h
stimul
addit
h
cell
stain
antibodi
antihuman
result
obtain
flow
cytometr
analysi
show
constitut
express
cell
signific
upregul
h
exposur
cell
p
pidotimod
figur
chang
express
obtain
expos
cell
pidotimod
h
h
figur
modif
induc
increas
express
observ
pretreat
cell
pidotimod
h
figur
analyz
express
cell
expos
h
pidotimod
zymosan
pidotimod
zymosan
enhanc
express
induc
exposur
stimuli
detect
immunofluoresc
microscopi
figur
quantifi
flow
cytometr
analysi
found
signific
expos
pidotimod
p
associ
pidotimod
p
figur
western
blot
figur
densitometr
analysi
demonstr
protein
level
effect
statist
signific
also
p
zymosan
p
combin
zymosan
pidotimod
p
figur
preincub
cell
pidotimod
h
modifi
result
shown
cell
expos
h
pidotimod
zymosan
zymosan
pidotimod
detect
concentr
found
supernat
cell
cultur
medium
alon
significantli
increas
cell
cultur
expos
h
zymosan
p
comparison
pidotimod
figur
modif
zymosaninduc
increas
releas
observ
addit
pidotimod
cell
cultur
final
preincub
cell
pidotimod
modifi
result
shown
analysi
confluent
cell
expos
pidotimod
pidotimod
min
increas
threoninetyrosin
phosphoryl
alreadi
detect
western
blot
min
cell
expos
pidotimod
figur
contrast
addit
pidotimod
cell
expos
induc
detect
decreas
phosphoryl
figur
densitometr
analysi
demonstr
inhibitori
effect
complet
min
figur
cell
treat
pidotimod
pidotimod
nfkb
detect
western
blot
analysi
cytoplasm
nuclear
extract
nfkb
express
upregul
cytoplasm
compart
exposur
pidotimod
associ
nfkb
nuclear
transloc
figur
b
similar
result
obtain
experi
perform
pidotimod
shown
use
human
bronchial
epitheli
cell
line
shown
pidotimod
abl
induc
vitro
cellular
chang
potenti
use
enhanc
capabl
host
fight
respiratori
infect
found
exposur
cell
pidotimod
effect
express
releas
detect
upregul
express
observ
fluoresc
microscopi
cytofluorimetri
western
blot
analysi
pidotimod
also
effect
induc
remark
inhibit
phosphoryl
opposit
signific
increas
nfkb
protein
express
nfkb
nuclear
transloc
pidotimod
synthet
dipeptid
molecul
biolog
immunolog
activ
adapt
innat
immun
respons
vitro
studi
anim
human
specimen
demonstr
signific
activ
innat
adapt
immun
respons
explain
remark
result
clinic
studi
reduct
rate
recurr
infect
upper
respiratori
tract
observ
emerg
evid
epidemiolog
clinic
anim
studi
indic
viral
infect
lead
caus
respiratori
morbid
young
children
import
environment
stimulu
airway
injuri
remodel
result
bronchial
hyperreact
impair
lung
function
potenti
persist
asthma
avail
pcr
techniqu
lead
signific
improv
viru
detect
rate
shown
hrv
princip
known
common
cold
virus
involv
pathogenesi
wheez
disord
young
children
approxim
differ
hrv
serotyp
known
util
specif
receptor
molecul
express
surfac
airway
epitheli
cell
hrv
infect
upregul
express
airway
epitheli
cell
thu
facilit
viral
attach
entri
besid
major
receptor
hrv
also
involv
transmigr
across
airway
epitheli
monolay
neutrophil
activ
disord
character
neutrophilmedi
acut
lung
injuri
therefor
observ
experiment
model
pidotimod
increas
constitut
induc
express
may
interpret
protect
function
avoid
enhanc
suscept
human
hrv
neutrophilmedi
damag
airway
surfac
similar
interpret
made
result
releas
power
chemotact
paracrin
mediat
neutrophil
infiltr
activ
neutrophil
play
key
role
pulmonari
inflamm
oxid
injuri
characterist
featur
respiratori
viral
infect
contrari
pidotimod
enhanc
constitut
express
rais
question
activ
pidotimod
airway
epitheli
cell
express
surfac
molecul
regul
differ
stimuli
also
dissimilar
intracellular
pathway
may
trigger
stimulu
exampl
activ
abl
opposit
effect
express
downregul
respect
differ
cell
type
characterist
pidotimod
abl
regul
differ
express
surfac
molecul
alreadi
demonstr
gourgioti
cowork
use
blood
mononuclear
cell
isol
atop
asthmat
normal
children
show
unknown
intracellular
mechan
pidotimod
downregul
express
induc
phytohaemoagglutinin
effect
human
leukocyt
antigen
hla
dr
molecul
tlr
class
protein
play
key
role
innat
immun
system
recogn
structur
conserv
molecul
deriv
microb
tlr
type
pattern
recognit
receptor
recogn
molecul
broadli
share
pathogen
distinguish
host
molecul
collect
refer
pathogenassoci
molecular
pattern
pamp
ten
mammalian
tlr
protein
identifi
thu
far
seem
least
discrimin
sinc
recogn
mani
bacteri
fungal
viral
certain
endogen
substanc
recognit
pamp
result
intern
phagocytosi
bound
molecul
cellular
activ
releas
cytokin
chemokin
variou
interleukin
cytokin
particip
nonspecif
immun
defens
includ
variou
interleukin
pampstlr
interact
surfac
cell
suffici
activ
flux
associ
induct
nfkb
airway
recent
studi
implic
tlr
especi
sentinel
receptor
abl
signal
interact
host
cell
bacteri
pathogen
via
nfkbmediat
pathway
interestingli
use
murin
macrophag
shown
mrna
may
induc
bacteri
infect
involv
sever
cytokin
includ
gmcsf
nfkb
necessari
maxim
transcript
underlin
tight
connect
nfkb
differ
effect
pidotimod
cell
report
may
least
partial
explain
opposit
effect
cell
function
produc
phosphoryl
nfkb
activ
extracellularsignalregul
kinas
erk
classic
mitogenactiv
protein
map
kinas
wide
express
protein
kinas
intracellular
signal
molecul
engag
regul
meiosi
mitosi
also
sever
post
mitot
function
includ
activ
involv
inflammatori
defens
process
includ
opposit
effect
express
agreement
result
cell
stimul
phosphoryl
cysteinyl
leukotrien
result
increas
express
bronchial
epitheli
cell
associ
enhanc
eosinophil
adhes
contrast
inhibit
phosphoryl
upregul
map
kinas
glucocorticoid
increas
express
hela
epitheli
cell
nfkb
protein
complex
found
almost
anim
cell
type
control
dna
transcript
involv
cellular
respons
varieti
stimuli
includ
bacteri
viral
antigen
nfkb
play
key
role
regul
quick
immun
respons
infect
belong
categori
rapidact
primari
transcript
factor
ie
present
cell
inact
state
requir
new
protein
synthesi
activ
involv
regul
reactiv
oxygen
speci
cytokin
adhes
molecul
product
identif
tlr
specif
pattern
recognit
molecul
find
express
regul
nfkb
also
tlr
stimul
lead
nfkb
activ
improv
understand
innat
adapt
immun
respons
infect
surprisingli
nfkb
activ
induc
pidotimod
result
increas
releas
howev
human
airway
epitheli
cell
cultur
mice
inhibit
phosphoryl
suppress
product
induc
exposur
sub
toxic
dose
cadmium
moreov
transcript
factor
involv
product
releas
includ
activ
protein
signal
transduc
activ
transcript
protein
stat
rather
pidotimod
elev
intracellular
level
reactiv
oxygen
speci
ro
lung
epitheli
cell
activ
pathway
therefor
upstream
transcript
factor
rossensit
signal
pathway
includ
mitogenactiv
protein
kinas
protein
kinas
c
may
involv
increas
inflammatori
gene
activ
shown
pidotimod
synthet
dipeptid
use
prevent
recurr
respiratori
infect
children
abl
modul
airway
epitheli
cell
function
involv
hostviru
possibl
nfkb
activ
obviou
limit
studi
experi
report
obtain
human
cell
line
confirm
vivo
activ
may
least
part
clarifi
mechan
action
molecul
airway
level
hrv
human
rhinoviru
ri
respiratori
insuffici
syndrom
tumor
necrosi
rant
regul
activ
normal
cell
express
secret
intercellular
adhes
tolllik
il
interleukin
nfkb
nuclear
factorkappa
b
erk
extracellularsignalregul
kinas
elisa
enzymelink
immunosorb
assay
dtt
dithiothreitol
ifni
interferon
hladr
human
leukocyt
antigendr
pamp
pathogenassoci
molecular
pattern
map
kinas
mitogenactiv
protein
kinas
ap
activ
protein
stat
signal
transduc
activ
transcript
protein
ro
reactiv
oxygen
speci
gar
receiv
past
five
year
reimburs
fee
fund
polichem
sa
luxembourg
valea
spa
milan
itali
way
gain
lose
financi
public
manuscript
sc
ms
declar
anyfinanci
compet
interest
author
made
substanti
contribut
concept
design
studi
analysi
interpret
acquisit
data
data
sc
perform
vitro
experi
ms
statist
analysi
author
involv
draft
manuscript
revis
critic
import
intellectu
content
author
read
approv
final
manuscript
